| 000 | 01931nam a2200373 i 4500 | ||
|---|---|---|---|
| 001 | 2133323 | ||
| 003 | StDuBDS | ||
| 005 | 20231010110649.0 | ||
| 006 | m|||||o||d|||||||| | ||
| 007 | cr ||||||||||| | ||
| 008 | 171117s2017 enka fob 001|0|eng|d | ||
| 020 |
_a9781910797716 (PDF ebook) : _cNo price |
||
| 020 |
_z9781910797709 (pbk.) : _cNo price |
||
| 020 | _z9781910797716 | ||
| 040 |
_aStDuBDS _beng _cStDuBDS _erda _epn |
||
| 060 | 4 | _aQW 601 | |
| 100 | 1 |
_aClarke, Stephen _c(Professor of medicine), _eauthor. |
|
| 245 | 1 | 0 |
_aImmuno-oncology / _h[e-book] |
| 264 | 1 |
_aAbingdon, Oxford : _bHealth Press, _c2017. |
|
| 300 |
_a1 online resource (88 pages) : _billustrations (colour). |
||
| 490 | 1 | _aFast facts | |
| 500 | _aAlso issued in print: 2017. | ||
| 504 | _aIncludes bibliographical references and index. | ||
| 520 | 8 | _aThe treatment of cancer is being revolutionised by drugs that modulate the immune system, offering the prospect of long-term response and extended survival for many patients with advanced incurable cancer. A plethora of new drugs are being incorporated into current standards of care but many questions remain unanswered - and new ones emerge - about how to use these exciting new drugs to best effect. A good understanding of immune-oncology is therefore becoming increasingly important to keep up to date with this rapidly changing field. | |
| 521 | _aSpecialized. | ||
| 588 | _aDescription based on online resource; title from PDF title page (viewed on January 17, 2023). | ||
| 650 | 0 |
_aImmunotherapy. _96577 |
|
| 650 | 0 |
_aTumors _xTreatment. |
|
| 650 | 2 |
_aImmunotherapy. _96577 |
|
| 650 | 2 |
_aNeoplasms _xtherapy. |
|
| 700 | 1 |
_aLi, Bob T., _eauthor. |
|
| 830 | 0 | _aFast facts. | |
| 856 | 4 | 0 |
_uhttps://app.kortext.com/Shibboleth.sso/Login?entityID=https://idp.eng.nhs.uk/openathens&target=https://app.kortext.com/borrow/2133323 _yEligible NHS OpenAthens account holders click here for access |
| 999 |
_c96841 _d96841 |
||